Press release
Chronic Obstructive Pulmonary Disease Drugs Market Upcoming Opportunities, Trends And Size Insights 2020 | AstraZeneca plc, Boehringer Ingelheim Pharmaceuticals Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc
Get Free Sample Chronic Obstructive Pulmonary Disease Drugs Market Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/chronic-obstructive-pulmonary-disease-drugs-market-101176
Leading Key players in the global Chronic Obstructive Pulmonary Disease Drugs include: AstraZeneca plc, Boehringer Ingelheim Pharmaceuticals Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc.
Rising Use of Tobacco Worldwide to Boost the Market
Tobacco smoke is the leading causative factor for COPD, according to the WHO. The WHO also states that tobacco kills around 8 million people every year, out which 1.2 million die due to second-hand smoke. Approximately 80% of the world's smokers are in low- and middle-income countries, the WHO further reports. Thus, there is a direct link between increasing tobacco abuse and rising prevalence of COPD, especially in the developing nations. The Centers for Disease Control and Prevention (CDC) also supports WHO's statistics by revealing that smoking is responsible for 80% of COPD-induced deaths in the US. More importantly, 25% of these deaths are of those who have never smoked. The combined rise of tobacco smokers and overall prevalence of COPD will surge the chronic obstructive pulmonary disease drugs market demand in the coming years.
Heavy Industrial Pollution to Propel the Market in North America
High pollution levels as a result of intense industrial activities will aid North America's dominance on the chronic obstructive pulmonary disease drugs market share over the forecast period. Presently, there are around 16 million people suffering from COPD in the US. Besides this, low awareness levels about COPD, excessive smoking, and rapid adoption of sedentary lifestyle will further drive the market in the region. In the developing nations of Asia-Pacific and Africa, growing prevalence of respiratory disorders will expand the COPD drugs market size in these regions. Additionally, rapid urbanization is fast emerging as a leading risk factor for COPD and other lung diseases in Asia-Pacific.
Global Chronic Obstructive Pulmonary Disease Drugs Market: Geographical Analysis:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Intended Audience:
Chronic Obstructive Pulmonary Disease Drugs Key Players
Chronic Obstructive Pulmonary Disease Drugs Suppliers
Research and Development (RandD) Companies
Distributer and Supplier companies
End Users
Consultants and Investment bankers
Government as well as Independent Regulatory Authorities
Table of content
Table of Contents
1 Market Overview
1.1 Chronic Obstructive Pulmonary Disease Drugs Market Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.4 South America, Middle East and Africa
1.5 Market Dynamics
Browse more at: https://www.fortunebusinessinsights.com/industry-reports/chronic-obstructive-pulmonary-disease-drugs-market-101176
About us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune Business Insights Pvt. Ltd.
Supreme Headquarters,
Pune Banglore Highway, Baner, Pune,
Maharashtra 411045, India
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Pune Banglore Highway Pashan Exit, Baner, Pune, Maharashtra 411045, India
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Obstructive Pulmonary Disease Drugs Market Upcoming Opportunities, Trends And Size Insights 2020 | AstraZeneca plc, Boehringer Ingelheim Pharmaceuticals Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc here
News-ID: 2054197 • Views: …
More Releases from Fortune Business Insights Pvt. Ltd
Wheat Flour Market Size, Share, Latest Trends, Top Companies and Forecast by 202 …
The global Wheat Flour Market Size is expected to rise with an impressive CAGR and generate the highest revenue by . Fortune Business Insights™ in its latest report published this information. The report is titled Wheat Flour Market Size, Share & Trends, ". The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period.
The global wheat flour market size was USD 155.08 billion in 2020…
Vanilla Extracts Market Size, Latest Trends, Revenue, Growth, Top Companies and …
The global Vanilla Extracts Market Size is expected to rise with an impressive CAGR and generate the highest revenue by . Fortune Business Insights™ in its latest report published this information. The report is titled Vanilla Extracts Market Size, Share & Trends, ". The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period.
The global vanilla extract market size was valued at USD 5.26 billion…
Hummus Market Share, Size, Top Companies, Latest Trends and Forecast by 2021-202 …
The global Hummus Market Size is expected to rise with an impressive CAGR and generate the highest revenue by . Fortune Business Insights™ in its latest report published this information. The report is titled Hummus Market Size, Share & Trends, ". The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period.
The global hummus market size was USD 2.62 billion in 2020 and is projected…
Frozen Food Market Trends, Size, Share, Growth and Forecast by 2028 | McCain Foo …
The global Frozen Food Market Size is expected to rise with an impressive CAGR and generate the highest revenue by . Fortune Business Insights™ in its latest report published this information. The report is titled Frozen Food Market Size, Share & Trends, ". The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period.
The global frozen food market size was USD 231.38 billion in 2020…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
